ACCELERON PHARMA INC (26) | Business Operations (2)
- Collaboration, License and Option Agreement between Acceleron Pharma Inc. and Celgene Corporation, dated as of August 2, 2011 (Filed With SEC on August 5, 2021)
- Letter Agreement to Amended and Restated Collaboration, License and Option Agreement between Acceleron Pharma Inc. and Celgene Corporation, dated as of March 10, 2020 (Filed With SEC on May 11, 2020)